Advocacy at a Glance 6/4/21 Advocacy at a Glance 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More Analysis and Commentary 5/28/21 Analysis and Commentary 5/28/21 President to Release FY 22 Budget Request Today Read More Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Advocacy at a Glance 5/16/21 Advocacy at a Glance 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Analysis and Commentary 5/8/21 Analysis and Commentary 5/8/21 FDA Priorities for FY 22 Read More Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Analysis and Commentary 4/16/21 Analysis and Commentary 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary 3/27/21 Analysis and Commentary 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary 3/19/21 Analysis and Commentary 3/19/21 Two Topical Political Issues Read More Analysis and Commentary 2/27/21 Analysis and Commentary 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Older Posts
Advocacy at a Glance 6/4/21 Advocacy at a Glance 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More
Analysis and Commentary 5/28/21 Analysis and Commentary 5/28/21 President to Release FY 22 Budget Request Today Read More
Advocacy at a Glance 5/28/21 Advocacy at a Glance 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Analysis and Commentary 5/21/21 Analysis and Commentary 5/21/21 Messaging for Upcoming Senate Hill Days Read More
Advocacy at a Glance 5/21/21 Advocacy at a Glance 5/21/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 5/16/21 Advocacy at a Glance 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Advocacy at a Glance 5/2/21 Advocacy at a Glance 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Analysis and Commentary 4/23/21 Analysis and Commentary 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Analysis and Commentary 4/16/21 Analysis and Commentary 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance 4/16/21 Advocacy at a Glance 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance 4/9/21 Advocacy at a Glance 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary 3/27/21 Analysis and Commentary 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance 3/27/21 Advocacy at a Glance 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary 3/19/21 Analysis and Commentary 3/19/21 Two Topical Political Issues Read More
Analysis and Commentary 2/27/21 Analysis and Commentary 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
